Heart to Heart Nurses is brought to you by the Preventive Cardiovascular Nurses Association. Each episode will provide you with knowledge and tools you can apply to the prevention and management of cardiovascular disease across the lifespan.
Cardiovascular Sequelae of COVID-19 in Adults includes myocaritis, long-COVID, and returning to play. Guest Ty Gluckman, MD, FACC, FAHA, co-chair of the related 2022 Expert Consensus Decision Pathway, shares clinical practices for ID and treatment of those with post-COVID sequelae, evaluating and managing patients who have--or have had--COVID-19, how CV symptoms may manifest weeks or months post-infection, the differences between PASC-CVD and PASC-CVS, and resources for you and your patients.
ACC expert consensus decision pathway:
https://www.jacc.org/doi/10.1016/j.jacc.2022.02.003
PCNA Membership
https://pcna.net/member-center/
PCNA Event calendar
https://pcna.net/professional-development/event-calendar/
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Cultural humility allows health care providers to effectively communicate by understanding the complexity of identies and experiences of our patients. Learn how cultural humility is defined, strategies for implementing it into practice to help improve interactions and patient outcomes, and health inequality factors that may impact our patients and their cardiovascular care. Guest Diana Baptise, DNP, RN, CNE, FPCNA, FAAN, is Assistant Professor – Center for Cardiovascular and Chronic Care at the Johns Hopkins School of Nursing.
PCNA Professional Development
https://pcna.net/professional-development/
Hypertrophic Cardiomyopathy (HCM) is the most common genetic heart disease in the United States, with 1 in 500 (0.2%) diagnosed with the condition worldwide. Learn about the basics: signs, symptoms and diagnosis of HCM with guest Jane A. Linderbaum MS, ARNP, FACC, Associate Professor of Medicine at the Mayo Clinic.
Patient Education Resource: Hypertrophic Cardiomyopathy: What You Need to Know
https://pcna.net/clinical-resources/patient-handouts/hypertrophic-cardiomyopathy-patient-tool/
Hypertrophic Cardiomyopathy (HCM) diagnosis and management complicated; symptoms may include shortness of breath, severe arrhythmias, or inability to exercise. Rarely, very vigorous physical activity may trigger dangerous arrhythmias and even sudden cardiac arrest. Centers of Excellence provide best practice approaches to optimize patient outcomes. Guests include Heidi Salisbury, RN, MSN, CNS, from Stanford University, and Carol Patrick, RN, ACNP, from Northwell Health.
2020 AHA/ ACC Guidelines for the Diagnosis and Treatment of Patients with Hypertrophic Cardiomyopathy , JACC, 76 (25), 2020.
https://www.jacc.org/doi/10.1016/j.jacc.2020.08.045
AHA Scientific Statement 12-step screening for SCD in High School Athletes 2016
HCM Centers of Excellence https://4hcm.org/center-of-excellence/
In Hypertrophic Cardiomyopathy (HCM), left ventricle wall thickening reduces the heart's ability to pump blood efficiently. HCM treatment options are limited, and shared decision-making with patients, family members, and healthcare teammates is crucial throughout the disease journey. Guest: Deatrah Dubose, APN, of the Chanin T. Mast Center at Atlantic Health.
https://www.medscape.com/viewarticle/975122
A relatively new field, and a fast growing subspecialty, cardio-oncology addresses cardiovascular disease, or side effects, associated with cancer. Guests Janet Celli, BSN, RN, PCCN, and Kerry Skurka, RN, BSN, F-ICOS, discuss the clinical implications for patients who may experience cardiovascular disease during, or following, cancer treatment.
Resources:
American College of Cardiology CardioSmart: cardiosmart.org
ICOS: ic-os.org
Cancer Support Community: cancersupportcommunity.org
Association of Community Cancer Centers: accc-cancer.org
Little Red Door: littlereddoor.org
Patients with cancer are at increased risk of cardiovascular disease, months or years following their final cancer treatment--and the comorbidities for cancer and CVD overlap significantly. Guests Janet Celli, BSN, RN, PCCN, and Kerry Skurka, RN, BSN, F-ICOS, discuss risk reduction and the impact of health equity in these patients.
K Red Door: littlereddoor.org
Cardio-oncology requires a team of individuals--primary care, oncology, cardiology, families, and caregivers--supporting the patient and the shared decision-making process. The COVID-19 pandemic effects on cardio-oncology are discussed, along with informational resources. Guests: Janet Celli, BSN, RN, PCCN, and Kerry Skurka, RN, BSN, F-ICOS.
Developing and demonstrating leadership--regardless of your job title--helps improve patient outcomes, job satisfaction, and career advancement. Learn about the Future of Nursing repot, and how mentorship, training, and resources can help you in your career journey. Guest: Sandra B. Dunbar, RN, PhD, FAAN, FAHA, FPCNA, of Emory University.
Advancing the Cardiovascular Nursing Profession: https://pcna.net/advancing-the-cardiovascular-nursing-profession/
PCNA Leadership Series: https://pcna.net/event/leadership-series-leadership-in-the-workplace/
